Skip to content
#federated learning Review Open access

Deep Learning and Ensemble Learning Techniques for Breast Cancer Detection: A Review of Recent Advances

Sep 2026 · INTERNATIONAL JOURNAL OF MATHEMATICS AND COMPUTER RESEARCH · 0 citations
AI in cancer detection

Abstract

Breast cancer remains the most frequently diagnosed cancer and a leading cause of cancer death among women worldwide, so tools that support early and accurate detection are urgently needed. This review synthesizes a pool of one hundred studies, largely published between 2023 and 2026, on deep learning, ensemble learning, and optimization algorithms for breast cancer detection across mammography, ultrasound, magnetic resonance imaging, and histopathology. Relevant studies were identified from major scientific databases using search terms combining breast cancer, deep learning, convolutional neural networks, ensemble learning, metaheuristic optimization, and adversarial robustness, then organized by architecture, ensemble strategy, and outcome. Convolutional Neural Networks such as VGG16/19, ResNet50, DenseNet121, EfficientNet, Xception, and MobileNet, typically adapted through transfer learning, consistently exceed 90% classification accuracy on benchmark datasets, while bagging, boosting, voting, and stacking ensembles yield further, consistent gains by exploiting complementary feature representations. Metaheuristic algorithms, including Particle Swarm, Genetic, Ant Colony, Grey Wolf, and Bayesian Optimization, are increasingly used to tune hyperparameters and ensemble weights, reducing computational overhead while preserving accuracy. Attention-augmented and hybrid CNN-transformer models, federated learning, and explainability tools such as Grad-CAM and SHAP are emerging as important extensions. Nevertheless, high computational cost, limited dataset diversity, restricted multimodal integration, susceptibility to adversarial perturbation, and weak interpretability continue to restrict clinical translation. The review concludes that optimized, explainable, and adversarially robust ensemble frameworks, validated through multi-center clinical trials, represent the most promising direction for translating deep learning research into dependable and deployable breast cancer detection systems.

Read PDF

Similar papers

#machine learning Review Open access Oct 2014

Software development in startup companies: A systematic mapping study

The results indicate that software engineering work practices are chosen opportunistically, adapted and configured to provide value under the constrains imposed by the startup context.

Nicolò Paternoster, Carmine Giardino, M. Unterkalmsteiner et al. · 394 citations · ⚡54
#machine learning Review Open access Jun 2014

Why Early-Stage Software Startups Fail: A Behavioral Framework

This state-of-practice investigation was performed using a literature review followed by a multiple-case study approach and presents how inconsistency between managerial strategies and execution can lead to failure by means of a behavioral framework.

Carmine Giardino, Xiaofeng Wang, P. Abrahamsson · 175 citations · ⚡19
#machine learning Review Open access Oct 2016

“Failures” to be celebrated: an analysis of major pivots of software startups

This study conducts a case survey study based on the secondary data of the major pivots happened in 49 software startups, and demonstrates that customer need pivot is the most common among all pivot types.

Sohaib Shahid Bajwa, Xiaofeng Wang, Anh Nguyen-Duc et al. · 127 citations · ⚡15
#machine learning Review Open access May 2016

Key Challenges in Software Startups Across Life Cycle Stages

It is found that what perceived as biggest challenges by software startups do vary across different life cycle stages, even though its significance decreases when the learning focuses of the startups move from problem to solution and their products mature.

Xiaofeng Wang, Henry Edison, Sohaib Shahid Bajwa et al. · 62 citations · ⚡6

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.